Cabaletta Bio, Inc.
Nasdaq · CIK 0001759138 · Fiscal year end 1231
Latest reported period: Latest published period
Operating Income
$-44.3M
Net Income
$-43.5M
Eps Basic
-0.39
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-44.3M | - | - |
| Net Income | $-43.5M | - | - |
| Eps Basic | -0.39 | - | - |
| Eps Diluted | -0.39 | - | - |
| Cash And Equivalents | $116.6M | - | - |
| Total Assets | $148.1M | - | - |
| Total Liabilities | $44.8M | - | - |
| Shareholders Equity | $103.3M | - | - |
| Operating Cash Flow | $-42.6M | - | - |
| Capital Expenditures | $0 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | Cabaletta Bio, Inc. | 2026-05-14 | 0001759138-26-000026 |
| 10-K | Cabaletta Bio, Inc. | 2026-03-23 | 0001759138-26-000011 |
| 4 | Cabaletta Bio, Inc. | 2026-01-21 | 0001193125-26-018319 |
| 4 | Cabaletta Bio, Inc. | 2026-01-21 | 0001193125-26-018318 |
| 4 | Cabaletta Bio, Inc. | 2026-01-21 | 0001193125-26-018327 |
| 4 | Cabaletta Bio, Inc. | 2026-01-21 | 0001193125-26-018317 |
| 4 | Cabaletta Bio, Inc. | 2026-01-21 | 0001193125-26-018325 |
| 4 | Cabaletta Bio, Inc. | 2026-01-21 | 0001193125-26-018316 |
| 4 | Cabaletta Bio, Inc. | 2026-01-21 | 0001193125-26-018324 |
| 4 | Cabaletta Bio, Inc. | 2026-01-21 | 0001193125-26-018323 |
| 10-Q | Cabaletta Bio, Inc. | 2025-11-10 | 0001193125-25-273280 |
| 10-Q | Cabaletta Bio, Inc. | 2025-08-07 | 0000950170-25-104573 |